Community pharmacists' recommendations for natural products for stress in Melbourne, Australia: a simulated patient study

Abstract Background: Community pharmacists are often the first health professional approached to provide treatment for health issues, including the important mental health challenge, stress. Over-the-counter products for stress almost always are complementary and alternative medicines (CAM) and in Australia no protocol exists for their recommendation and sale in community pharmacies. Objective: To assess the quality and relevance of community pharmacists' information gathering (questioning), counselling and product selection when interacting with customers requesting a CAM product for stress and consequently determine whether Australian pharmacy practice indicates the need for guidelines similar to those provided for ‘pharmacy only' (S2) and ‘pharmacist only' (S3) medicines. Methods: A covert simulated patient was used to investigate the response of pharmacists to a request for a natural product for stress. The SPs documented the details of the pharmacist-simulated patient interaction immediately on leaving the pharmacy and then re-entered the pharmacy to debrief the pharmacist. The quality of the interaction was scored as a Total CARE (check, assess, respond, explain) Score, based on anticipated questions and counselling advice. The appropriateness of the product was scored as a Product Efficacy Score, based on evidence-based literature. Results: Data from 100 pharmacies was provided. Information gathering illustrated by the questioning components Check and Assess (C and A) of the total CARE score by pharmacists was poor. The number of questions asked ranged from zero (13 pharmacists) to 7 (four pharmacists), the average being 3.1 (SD 1.9). Provision of advice was generally better (a description of the suggested product was offered by 87 pharmacists) but was lacking in other areas (duration of use and side effects were explained by only 41 and 16 pharmacists respectively). The most common product suggested was B-group vitamins (57 pharmacists) followed by a proprietary flower essence product (19 pharmacists). A two-step cluster analysis revealed two sub-groups of pharmacists: one cluster (74 pharmacists) with a high Total CARE score provided an appropriate product. The other cluster (20 pharmacists) had a low total CARE score and provided an inappropriate product. Conclusions: The pharmacy visits revealed major shortcomings in questioning, counselling and product recommendation. There is a need to develop guidelines for pharmacists to make evidence-based decisions in recommending complementary and alternative medicine.

Saved in:
Bibliographic Details
Main Authors: Clayton,Kevin, Luxford,Yoni, Colaci,Joshua, Hasan,Meral, Miltiadou,Rebecca, Novikova,Daria, Vlahopoulos,Dean, Stupans,Ieva
Format: Digital revista
Language:English
Published: Centro de Investigaciones y Publicaciones Farmacéuticas 2020
Online Access:http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1885-642X2020000100003
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1885-642X2020000100003
record_format ojs
spelling oai:scielo:S1885-642X20200001000032021-04-19Community pharmacists' recommendations for natural products for stress in Melbourne, Australia: a simulated patient studyClayton,KevinLuxford,YoniColaci,JoshuaHasan,MeralMiltiadou,RebeccaNovikova,DariaVlahopoulos,DeanStupans,Ieva Complementary Therapies Nonprescription Drugs Counseling Mental Health Pharmacies Pharmacists Patient Simulation Cluster Analysis Australia Abstract Background: Community pharmacists are often the first health professional approached to provide treatment for health issues, including the important mental health challenge, stress. Over-the-counter products for stress almost always are complementary and alternative medicines (CAM) and in Australia no protocol exists for their recommendation and sale in community pharmacies. Objective: To assess the quality and relevance of community pharmacists' information gathering (questioning), counselling and product selection when interacting with customers requesting a CAM product for stress and consequently determine whether Australian pharmacy practice indicates the need for guidelines similar to those provided for ‘pharmacy only' (S2) and ‘pharmacist only' (S3) medicines. Methods: A covert simulated patient was used to investigate the response of pharmacists to a request for a natural product for stress. The SPs documented the details of the pharmacist-simulated patient interaction immediately on leaving the pharmacy and then re-entered the pharmacy to debrief the pharmacist. The quality of the interaction was scored as a Total CARE (check, assess, respond, explain) Score, based on anticipated questions and counselling advice. The appropriateness of the product was scored as a Product Efficacy Score, based on evidence-based literature. Results: Data from 100 pharmacies was provided. Information gathering illustrated by the questioning components Check and Assess (C and A) of the total CARE score by pharmacists was poor. The number of questions asked ranged from zero (13 pharmacists) to 7 (four pharmacists), the average being 3.1 (SD 1.9). Provision of advice was generally better (a description of the suggested product was offered by 87 pharmacists) but was lacking in other areas (duration of use and side effects were explained by only 41 and 16 pharmacists respectively). The most common product suggested was B-group vitamins (57 pharmacists) followed by a proprietary flower essence product (19 pharmacists). A two-step cluster analysis revealed two sub-groups of pharmacists: one cluster (74 pharmacists) with a high Total CARE score provided an appropriate product. The other cluster (20 pharmacists) had a low total CARE score and provided an inappropriate product. Conclusions: The pharmacy visits revealed major shortcomings in questioning, counselling and product recommendation. There is a need to develop guidelines for pharmacists to make evidence-based decisions in recommending complementary and alternative medicine.Centro de Investigaciones y Publicaciones FarmacéuticasPharmacy Practice (Granada) v.18 n.1 20202020-03-01journal articletext/htmlhttp://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1885-642X2020000100003en
institution SCIELO
collection OJS
country España
countrycode ES
component Revista
access En linea
databasecode rev-scielo-es
tag revista
region Europa del Sur
libraryname SciELO
language English
format Digital
author Clayton,Kevin
Luxford,Yoni
Colaci,Joshua
Hasan,Meral
Miltiadou,Rebecca
Novikova,Daria
Vlahopoulos,Dean
Stupans,Ieva
spellingShingle Clayton,Kevin
Luxford,Yoni
Colaci,Joshua
Hasan,Meral
Miltiadou,Rebecca
Novikova,Daria
Vlahopoulos,Dean
Stupans,Ieva
Community pharmacists' recommendations for natural products for stress in Melbourne, Australia: a simulated patient study
author_facet Clayton,Kevin
Luxford,Yoni
Colaci,Joshua
Hasan,Meral
Miltiadou,Rebecca
Novikova,Daria
Vlahopoulos,Dean
Stupans,Ieva
author_sort Clayton,Kevin
title Community pharmacists' recommendations for natural products for stress in Melbourne, Australia: a simulated patient study
title_short Community pharmacists' recommendations for natural products for stress in Melbourne, Australia: a simulated patient study
title_full Community pharmacists' recommendations for natural products for stress in Melbourne, Australia: a simulated patient study
title_fullStr Community pharmacists' recommendations for natural products for stress in Melbourne, Australia: a simulated patient study
title_full_unstemmed Community pharmacists' recommendations for natural products for stress in Melbourne, Australia: a simulated patient study
title_sort community pharmacists' recommendations for natural products for stress in melbourne, australia: a simulated patient study
description Abstract Background: Community pharmacists are often the first health professional approached to provide treatment for health issues, including the important mental health challenge, stress. Over-the-counter products for stress almost always are complementary and alternative medicines (CAM) and in Australia no protocol exists for their recommendation and sale in community pharmacies. Objective: To assess the quality and relevance of community pharmacists' information gathering (questioning), counselling and product selection when interacting with customers requesting a CAM product for stress and consequently determine whether Australian pharmacy practice indicates the need for guidelines similar to those provided for ‘pharmacy only' (S2) and ‘pharmacist only' (S3) medicines. Methods: A covert simulated patient was used to investigate the response of pharmacists to a request for a natural product for stress. The SPs documented the details of the pharmacist-simulated patient interaction immediately on leaving the pharmacy and then re-entered the pharmacy to debrief the pharmacist. The quality of the interaction was scored as a Total CARE (check, assess, respond, explain) Score, based on anticipated questions and counselling advice. The appropriateness of the product was scored as a Product Efficacy Score, based on evidence-based literature. Results: Data from 100 pharmacies was provided. Information gathering illustrated by the questioning components Check and Assess (C and A) of the total CARE score by pharmacists was poor. The number of questions asked ranged from zero (13 pharmacists) to 7 (four pharmacists), the average being 3.1 (SD 1.9). Provision of advice was generally better (a description of the suggested product was offered by 87 pharmacists) but was lacking in other areas (duration of use and side effects were explained by only 41 and 16 pharmacists respectively). The most common product suggested was B-group vitamins (57 pharmacists) followed by a proprietary flower essence product (19 pharmacists). A two-step cluster analysis revealed two sub-groups of pharmacists: one cluster (74 pharmacists) with a high Total CARE score provided an appropriate product. The other cluster (20 pharmacists) had a low total CARE score and provided an inappropriate product. Conclusions: The pharmacy visits revealed major shortcomings in questioning, counselling and product recommendation. There is a need to develop guidelines for pharmacists to make evidence-based decisions in recommending complementary and alternative medicine.
publisher Centro de Investigaciones y Publicaciones Farmacéuticas
publishDate 2020
url http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1885-642X2020000100003
work_keys_str_mv AT claytonkevin communitypharmacistsrecommendationsfornaturalproductsforstressinmelbourneaustraliaasimulatedpatientstudy
AT luxfordyoni communitypharmacistsrecommendationsfornaturalproductsforstressinmelbourneaustraliaasimulatedpatientstudy
AT colacijoshua communitypharmacistsrecommendationsfornaturalproductsforstressinmelbourneaustraliaasimulatedpatientstudy
AT hasanmeral communitypharmacistsrecommendationsfornaturalproductsforstressinmelbourneaustraliaasimulatedpatientstudy
AT miltiadourebecca communitypharmacistsrecommendationsfornaturalproductsforstressinmelbourneaustraliaasimulatedpatientstudy
AT novikovadaria communitypharmacistsrecommendationsfornaturalproductsforstressinmelbourneaustraliaasimulatedpatientstudy
AT vlahopoulosdean communitypharmacistsrecommendationsfornaturalproductsforstressinmelbourneaustraliaasimulatedpatientstudy
AT stupansieva communitypharmacistsrecommendationsfornaturalproductsforstressinmelbourneaustraliaasimulatedpatientstudy
_version_ 1755999660150882304